Proton Pump Proton Pump

Cat.No.	Name	Information
M4953	Bafilomycin A1	Bafilomycin A1 (BafA1) is a vacuolar H⁺-ATPase inhibitor with IC50 of 0.44 nM.
M5728	Lansoprazole	Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.
M29007	Abeprazan	Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases.
M20496	Ilaprazole sodium	Ilaprazole sodium is the sodium salt form of ilaprazole, which is a proton pump inhibitor.
M20452	Revaprazan Hydrochloride	Revaprazan Hydrochloride is a new reversible proton pump inhibitor with long-lasting acid-suppressive effects.
M20397	Pantoprazole	Pantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.
M14266	Soraprazan	Soraprazan (BYK61359) is a selective, reversible K-competitive inhibitor of the H,K-ATPase (K_i=6.4 nM), with an IC₅₀ of 0.19 μM in gastric glands.
M14265	Pantoprazole sodium hydrate	Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium hydrate is also a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM.